Intrathecal pemetrexed Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Also known as: pemetrexed

Pipeline

Phase 2: 1

Top Sponsors

Shuanghu Yuan1
Hunan Province Tumor Hospital1

Indications

Lung Cancer2
Cancer2
Leptomeningeal Metastasis From Lung Cancer1
Non Small Cell Lung Cancer1

Other2 trials

Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases

Phase 2

ctDNA-driven Adaptive Proton Craniospinal Irradiation in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis After Resistance to Third-Generation TKIs in the Consolidation Phase

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.